PACS Group (PACS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on PACS Group (PACS) is Neutral.

The composite score behind that read is -0.10, weighing +0.37 of bullish evidence against -0.32 bearish.

PACS Group last closed at $42.71, -0.33% on the session.

Against the IVW growth benchmark the position is -1.25% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

13 graded predictions for PACS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks PACS Group in the 35th percentile on valuation and the 86th percentile on return on equity, where 100 is best.

PACS Group is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $6.78B.

StockMap tracks PACS Group as the 23rd largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite PACS Group ranks 29th of 72 in the group, against a group median of -0.13.

Other Health Care stocks

PACS Group (PACS) — StockMap 2-week forecast & tracked accuracy